8:10 AM ET
8-K
M&A Deal
Silence Therapeutics M&A Deal with Merck KGaA
Silence Therapeutics announced it has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany. The transaction is expected to close in the first quarter of 2027, subject to customary closing conditions and shareholder approval. While the filing also contains Q3 2026 financial results, the pending acquisition is the primary material event for investors.
- Counterparty
- Merck KGaA